Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism PPARα inhibitors(Peroxisome proliferator-activated receptor α inhibitors), PPARγ antagonists(Peroxisome proliferator-activated receptor γ antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus, Type 2 | Preclinical | IN | 15 Feb 2023 | |
Diabetes Mellitus, Type 2 | Preclinical | IN | 15 Feb 2023 | |
Diabetes Mellitus, Type 2 | Preclinical | IT | 15 Feb 2023 | |
Diabetes Mellitus, Type 2 | Preclinical | - | 15 Feb 2023 | |
Diabetes Mellitus, Type 2 | Preclinical | - | 15 Feb 2023 | |
Diabetes Mellitus, Type 2 | Preclinical | - | 15 Feb 2023 |